当前位置:首页 - 行情中心 - 科华生物(002022) - 财务分析 - 现金流量表

科华生物

(002022)

  

流通市值:26.33亿  总市值:27.21亿
流通股本:5.14亿   总股本:5.31亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,273,291,907.27819,044,600.09379,425,042.731,868,325,054.15
  收到的税费返还61,849,141.4653,872,432.055,122,909.411,837,220.82
  收到其他与经营活动有关的现金39,604,256.9916,205,705.315,110,329.147,651,495.34
  经营活动现金流入小计1,374,745,305.72889,122,737.45389,658,281.241,917,813,770.31
  购买商品、接受劳务支付的现金819,763,244.31509,443,938.45252,100,875.29976,696,203.78
  支付给职工以及为职工支付的现金352,526,600.84249,065,524.71136,710,222.56489,025,221.42
  支付的各项税费40,769,867.0329,201,276.1112,026,357.5355,470,658.5
  支付其他与经营活动有关的现金227,055,771.38155,861,172.9291,183,883.63374,183,021.23
  经营活动现金流出小计1,440,115,483.56943,571,912.19492,021,339.011,895,375,104.93
  经营活动产生的现金流量净额-65,370,177.84-54,449,174.74-102,363,057.7722,438,665.38
二、投资活动产生的现金流量:
  收回投资收到的现金60,000,00060,000,00060,000,000-
  取得投资收益收到的现金2,357,3512,085,021.811,132,217.782,038,529.93
  处置固定资产、无形资产和其他长期资产收回的现金净额3,021,008.393,835,989.652,034,241.248,099,734.38
  处置子公司及其他营业单位收到的现金净额481,412.64963,213.28463,213.281,500,000
  投资活动现金流入小计65,859,772.0366,884,224.7463,629,672.311,638,264.31
  购建固定资产、无形资产和其他长期资产支付的现金87,930,932.9758,600,050.9121,822,356.82139,293,855.38
  投资支付的现金2,100,0002,100,0002,100,00060,000,000
  投资活动现金流出小计90,030,932.9760,700,050.9123,922,356.82199,293,855.38
  投资活动产生的现金流量净额-24,171,160.946,184,173.8339,707,315.48-187,655,591.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金78,890,262--2,250,000
  其中:子公司吸收少数股东投资收到的现金---2,250,000
  取得借款收到的现金431,042,176304,551,215.92134,496,697.9611,920,500.57
  收到其他与筹资活动有关的现金17,906,80718,847,852.43-37,003,419.55
  筹资活动现金流入小计527,839,245323,399,068.35134,496,697.9651,173,920.12
  偿还债务支付的现金666,502,366.43259,818,969.81119,440,340.28403,316,268.52
  分配股利、利润或偿付利息支付的现金26,294,703.859,821,392.534,653,610.1765,642,516.34
  其中:子公司支付给少数股东的股利、利润3,612,0003,612,000-50,197,000
  支付其他与筹资活动有关的现金33,266,411.5927,235,639.273,762,393.8324,934,036.64
  筹资活动现金流出小计726,063,481.87296,876,001.61127,856,344.28493,892,821.5
  筹资活动产生的现金流量净额-198,224,236.8726,523,066.746,640,353.62157,281,098.62
四、汇率变动对现金及现金等价物的影响-3,906,066.55-6,342,369.79-1,320,334.43732,215.21
五、现金及现金等价物净增加额-291,671,642.2-28,084,303.96-57,335,723.1-7,203,611.86
  加:期初现金及现金等价物余额853,173,646.06853,173,646.06853,173,646.06860,377,257.92
  期末现金及现金等价物余额561,502,003.86825,089,342.1795,837,922.96853,173,646.06
补充资料:
  净利润--95,243,225.66--884,793,893.44
  资产减值准备-15,151,711.48-305,448,001.29
  固定资产和投资性房地产折旧-54,049,813-128,017,469.4
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-54,049,813-128,017,469.4
  无形资产摊销-30,589,822.06-83,941,322.01
  长期待摊费用摊销-3,908,853.68-21,113,117.96
  处置固定资产、无形资产和其他长期资产的损失--1,279,940.73--3,869,704.67
  固定资产报废损失-242,097.86-2,839,379.44
  公允价值变动损失-43,234.35--32,174.4
  财务费用-13,585,196.21-21,001,224.93
  投资损失--2,546,207.52--1,686,331.97
  递延所得税--388,369.6-58,518,007.93
  其中:递延所得税资产减少-69,444.29-60,030,776.11
    递延所得税负债增加--457,813.89--1,512,768.18
  存货的减少-15,504,484.14--5,211,881.26
  经营性应收项目的减少--20,667,658.29-76,356,619.51
  经营性应付项目的增加--86,038,706.18-40,882,898.38
  一年内到期的可转换公司债券-224,441,500-221,497,989.83
  现金的期末余额-825,089,342.1-853,173,646.06
  减:现金的期初余额-853,173,646.06-860,377,257.92
  现金及现金等价物的净增加额--28,084,303.96--7,203,611.86
公告日期2026-10-302026-08-282026-04-282026-04-17
审计意见(境内)标准无保留意见
TOP↑